1-6 of 6
Yong Li
Close
Sort by
Journal Articles

EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential

Yong Li, Zijun Y. Xu-Monette, Jeremy Abramson, Aliyah R. Sohani, Govind Bhagat, Alexandar Tzankov, Carlo Visco, Shanxiang Zhang, Karen Dybkaer, Zenggang Pan, Min Xu, Wayne Tam, Youli Zu, Eric D. Hsi, Fredrick B. Hagemeister, Heounjeong Go, J. Han van Krieken, Jane N. Winter, Maurilio Ponzoni, Andrés J. M. Ferreri, Michael B. Møller, Miguel A. Piris, Yingjun Wang, Mingzhi Zhang, Ken H. Young
Journal: Blood Advances
Blood Adv (2023) 7 (7): 1308–1311.
https://doi.org/10.1182/bloodadvances.2022008550
Published: 2023
Includes: Supplemental data
Journal Articles

Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia

Clinical Trials & Observations
Paul M. Barr, Carolyn Owen, Tadeusz Robak, Alessandra Tedeschi, Osnat Bairey, Jan A. Burger, Peter Hillmen, Steve E. Coutre, Claire Dearden, Sebastian Grosicki, Helen McCarthy, Jian-Yong Li, Fritz Offner, Carol Moreno, Cathy Zhou, Emily Hsu, Anita Szoke, Thomas J. Kipps, Paolo Ghia
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3440–3450.
https://doi.org/10.1182/bloodadvances.2021006434
Published: 2022
Includes: Supplemental data
Journal Articles

Tetherin/BST2, a physiologically and therapeutically relevant regulator of platelet receptor signalling

Xiaojuan Zhao, Dominic Alibhai, Ting Sun, Jawad Khalil, James L. Hutchinson, Kaya Olzak, Christopher M. Williams, Yong Li, Richard Sessions, Stephen Cross, Richard Seager, Riyaad Aungraheeta, Alan Leard, Caroline M. McKinnon, David Phillips, Lei Zhang, Alastair W. Poole, George Banting, Stuart J. Mundell
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1884–1898.
https://doi.org/10.1182/bloodadvances.2020003182
Published: 2021
Includes: Supplemental data
Journal Articles

Loss of the exocyst complex component EXOC3 promotes hemostasis and accelerates arterial thrombosis

Tony G. Walsh, Yong Li, Christopher M. Williams, Elizabeth W. Aitken, Robert K. Andrews, Alastair W. Poole
Journal: Blood Advances
Blood Adv (2021) 5 (3): 674–686.
https://doi.org/10.1182/bloodadvances.2020002515
Published: 2021
Includes: Supplemental data
Journal Articles

A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL

Zijun Y. Xu-Monette, Hongwei Zhang, Feng Zhu, Alexandar Tzankov, Govind Bhagat, Carlo Visco, Karen Dybkaer, April Chiu, Wayne Tam, Youli Zu, Eric D. Hsi, Hua You, Jooryung Huh, Maurilio Ponzoni, Andrés J. M. Ferreri, Michael B. Møller, Benjamin M. Parsons, J. Han van Krieken, Miguel A. Piris, Jane N. Winter, Fredrick B. Hagemeister, Babak Shahbaba, Ivan De Dios, Hong Zhang, Yong Li, Bing Xu, Maher Albitar, Ken H. Young
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3391–3404.
https://doi.org/10.1182/bloodadvances.2020001949
Published: 2020
Includes: Supplemental data
Journal Articles

Platelet-specific deletion of SNAP23 ablates granule secretion, substantially inhibiting arterial and venous thrombosis in mice

Christopher M. Williams, Yong Li, Edward Brown, Alastair W. Poole
Journal: Blood Advances
Blood Adv (2018) 2 (24): 3627–3636.
https://doi.org/10.1182/bloodadvances.2018023291
Published: 2018